[Clinical application of 113mIn-chloride for indirect lower radionuclide lymphography in cancer patients].
Carrier-free applications of 113mIn-chloride for indirect lower radionuclide lymphography were studied in 90 cancer patients. The period of radiolabel semiexcretion from site of injection (initial interdigital spaces of foot) ranged 25-74 min. 131mIn-chloride application provided a distinct visualization of retroperitoneal lymph nodes. The results of a radionuclide lymphographic study of 43 patients with uterine carcinoma were confirmed by postoperative histological examination of resected lymph nodes in 88%. The informative value of the pictures of retroperitoneal lymph nodes obtained by gamma chambers and scanners using 131mIn-chloride was essentially identical.
D003951:Diagnostic Errors; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D006801:Humans; D007204:Indium; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008207:Lymphatic Metastasis; D008220:Lymphography / Q000379:methods; D008297:Male; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D011877:Radionuclide Imaging; D012187:Retroperitoneal Space; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology
D007204:Indium; C020758:indium trichloride
Klinicheskiĭ opyt primeneniia 113mIn-khlorida dlia nepriamoĭ nizhneĭ radionuklidnoĭ limfografii u onkologicheskikh bol'nykh.